PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.
- DOI
- 10.1038/s41598-026-51900-5
- Published
- 2026 May 7
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-51900-5,
title = {PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.},
author = {Kumar AR and Dharshini MD and Devan AR and Unni AR and Sithara MS and Nair B and Kamath AJ and Sah SK and Pavithran K and Sabitha M and Sudheesh MS and Nath LR},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-51900-5},
url = {https://doi.org/10.1038/s41598-026-51900-5}
}RIS
TY - JOUR TI - PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials. AU - Kumar AR AU - Dharshini MD AU - Devan AR AU - Unni AR AU - Sithara MS AU - Nair B AU - Kamath AJ AU - Sah SK AU - Pavithran K AU - Sabitha M AU - Sudheesh MS AU - Nath LR PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-51900-5 UR - https://doi.org/10.1038/s41598-026-51900-5 ER -
APA
AR, K., MD, D., AR, D., AR, U., MS, S., B, N., AJ, K., SK, S., K, P., M, S., MS, S., & LR, N. (2026). PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.. Scientific reports. https://doi.org/10.1038/s41598-026-51900-5
Source records
- pubmed · retrieved 2026-09-26T22:12:58.950Z